Open AccessEffect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
Author(s) -
F. Saad,
D. Cella,
E. Basch,
B.A. Hadaschik,
P.N. Mainwaring,
S. Oudard,
J.N. Graff,
K. McQuarrie,
S. Li,
S. Hudgens,
J. Lawson,
A. Lopez-Gitlitz,
M.K. Yu,
M.R. Smith,
E.J. Small
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/4rp5-1y76
Subject(s) - prostate cancer , placebo , medicine , oncology , quality of life (healthcare) , randomized controlled trial , cancer , alternative medicine , pathology , nursing